All sites C00-96,D32-33,D42-43,D45-47,D76 2681 89.3 1.8 3.1 1.1 4.7
Mouth, pharynx C00-14 44 97.7 1.8 0.5 - -
  Lip C00 6 96.6 - 3.4 - -
  Tongue C02 12 100.0 - - - -
  Mouth, other C03-06 14 100.0 - - - -
  Salivary glands C07-08 5 85.2 14.8 - - -
  Pharynx C01,C09-14 8 100.0 - - - -
Digestive organs C15-26 507 79.6 0.8 8.8 2.3 8.6
  Oesophagus C15 17 96.4 - 1.2 1.2 1.2
  Stomach C16 49 95.1 - 0.4 0.4 4.0
  Small intestine C17 8 92.5 - 5.0 2.5 -
  Colon C18 181 92.8 0.1 2.7 0.8 3.7
  Rectum, rectosigmoid C19-20 77 97.7 - 0.8 0.5 1.0
  Anus C21 5 95.8 - - - 4.2
  Liver C22 27 71.5 4.4 14.6 2.9 6.6
  Gallbladder, bile ducts C23-24 24 48.7 2.5 21.8 5.0 21.8
  Pancreas C25 108 47.4 1.9 25.2 5.2 20.4
  Other digestive organs C26 12 30.5 - 16.9 13.6 39.0
Respiratory organs C30-39 164 74.2 8.2 7.8 2.1 7.7
  Nose, sinuses C30-31 3 100.0 - - - -
  Larynx, epiglottis C32 3 100.0 - - - -
  Lung, trachea C33-34 155 74.1 8.5 8.0 1.9 7.5
  Mediastinum, pleura C38 1 - - 66.7 - 33.3
Bone C40-41 3 93.3 - - - 6.7
Melanoma of the skin C43 113 100.0 - - - -
Skin, non-melanoma C44 138 99.7 0.1 - - 0.1
Mesothelioma C45 5 96.2 3.8 - - -
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 17 96.4 - 1.2 1.2 1.2
Breast C50 834 99.4 0.2 0.1 0.1 0.3
Female genital organs C51-58 293 93.2 1.1 1.8 1.6 2.2
  Cervix uteri C53 26 98.4 0.8 - - 0.8
  Corpus uteri C54 142 97.8 0.1 0.4 0.7 1.0
  Uterus, other C55,C58 2 54.5 - 18.2 18.2 9.1
  Ovary C56 88 87.4 2.5 4.6 1.8 3.7
  Other female genital C51-52,C57 35 87.6 1.7 1.1 5.1 4.5
Urinary organs C64-68 118 88.1 0.8 4.4 1.0 5.6
  Kidney C64 68 85.8 - 6.5 1.5 6.2
  Bladder and urinary tract2 C65-68 50 91.2 2.0 1.6 0.4 4.8
Eye C69 2 70.0 - - 10.0 20.0
Brain, central nervous system C70-72,D32-33,D42-43 100 88.8 - 3.2 0.8 7.2
Thyroid gland C73 47 95.3 3.0 0.8 - 0.8
Other endocrine glands C74-75 2 87.5 - - 12.5 -
Illdefined or unknown C76,C80 67 55.1 6.3 13.4 3.6 21.7
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 226 75.8 8.2 0.2 1.8 14.1
  Hodgkin lymphoma C81 13 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 99 96.4 0.8 0.2 0.4 2.2
  Malignant immunoproliferative diseases C88 2 80.0 - - - 20.0
  Myeloma and other plasma cell tumors C90 28 55.4 15.8 0.7 4.3 23.7
  Leukaemia C91-95 49 59.3 19.5 - 2.4 18.7
  Myelodysplastic syndromes D46 12 21.3 18.0 - - 60.7
  Myeloproliferaitive neoplasms D45,D47 23 62.1 6.9 - 5.2 25.9
Not included above
  Carcinoma in situ of the breast D05 68 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 184 100.0 - - - -
  Borderline tumour of the ovary D39 25 98.4 - - - 1.6
  Basal cell carcinoma of the skin 750 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.